Cancer-testing company raises $494 million in initial public offering.

Caris Life Sciences raised $494.1 million in its Nasdaq initial public offering, the cancer diagnostic firm said on Tuesday, ...

Caris plans to use the proceeds from its IPO to pay off about $400 million worth of debt, he noted, and it also intends to use the funds to drive toward profitability next year and continue expanding ...

The stock of Caris Life Sciences shined in its Nasdaq debut on Wednesday, pricing its heavily-subscribed initial public ...

With the successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion.

Shares of Caris Life Sciences soared in their public debut Wednesday, as investors bought into the company’s business of ...

Caris Life Sciences shares rose on their first day of trading in their debut on Nasdaq. The biotechnology company started trading at $27 each on Wednesday afternoon, a day after the company's IPO was ...

Live Updates Live Coverage Updates appear automatically as they are published. Housing Market Teetering 10:20 am by Gerelyn ...

Live Updates Live Coverage Updates appear automatically as they are published. Housing Market Weakness 9:52 am by Gerelyn ...

The 30-stock Dow lost 44.14 points, or 0.10%, and ended at 42,171.66. The S&P 500 slipped 0.03% to close at 5,980.87, and the ...

The biotech firm filed its IPO paperwork May 23 in a bid to boost its finances, noting there was "substantial doubt" about ...

The cancer diagnostics and treatment company priced above its previously planned range and might signal a renewed appetite ...